Mirae Asset Global Investments Co. Ltd. Has $3.16 Million Stock Holdings in STERIS plc $STE

Mirae Asset Global Investments Co. Ltd. grew its position in shares of STERIS plc (NYSE:STEFree Report) by 7.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,143 shares of the medical equipment provider’s stock after purchasing an additional 885 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in STERIS were worth $3,157,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in STE. Merit Financial Group LLC raised its position in shares of STERIS by 50.4% during the first quarter. Merit Financial Group LLC now owns 1,905 shares of the medical equipment provider’s stock worth $432,000 after acquiring an additional 638 shares during the last quarter. Wedmont Private Capital bought a new position in shares of STERIS during the first quarter worth about $241,000. Park Avenue Securities LLC raised its position in shares of STERIS by 12.7% during the first quarter. Park Avenue Securities LLC now owns 2,671 shares of the medical equipment provider’s stock worth $605,000 after acquiring an additional 302 shares during the last quarter. Portside Wealth Group LLC raised its position in shares of STERIS by 18.6% during the first quarter. Portside Wealth Group LLC now owns 1,616 shares of the medical equipment provider’s stock worth $366,000 after acquiring an additional 253 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its position in shares of STERIS by 8.3% during the first quarter. Farther Finance Advisors LLC now owns 2,488 shares of the medical equipment provider’s stock worth $562,000 after acquiring an additional 190 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on STE shares. KeyCorp raised their price objective on STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 22nd. Wall Street Zen upgraded STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Morgan Stanley lifted their target price on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a report on Friday, August 8th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of STERIS in a report on Saturday, September 27th. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $273.50.

View Our Latest Research Report on STE

STERIS Trading Up 0.4%

NYSE STE opened at $241.58 on Wednesday. The company has a market cap of $23.79 billion, a price-to-earnings ratio of 37.00 and a beta of 1.01. STERIS plc has a 52 week low of $200.98 and a 52 week high of $253.00. The business has a 50 day moving average price of $243.63 and a 200-day moving average price of $235.54. The company has a quick ratio of 1.53, a current ratio of 2.22 and a debt-to-equity ratio of 0.27.

STERIS (NYSE:STEGet Free Report) last released its quarterly earnings data on Wednesday, August 6th. The medical equipment provider reported $2.34 EPS for the quarter, beating the consensus estimate of $2.32 by $0.02. The firm had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.36 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.03 earnings per share. As a group, equities analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 26th. Stockholders of record on Thursday, September 4th were issued a dividend of $0.63 per share. This is a positive change from STERIS’s previous quarterly dividend of $0.57. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Thursday, September 4th. STERIS’s dividend payout ratio is presently 38.59%.

Insider Transactions at STERIS

In other news, VP Renato Tamaro sold 3,204 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $249.24, for a total transaction of $798,564.96. Following the completion of the sale, the vice president owned 7,221 shares in the company, valued at $1,799,762.04. The trade was a 30.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Mohsen Sohi sold 4,110 shares of STERIS stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $241.96, for a total value of $994,455.60. Following the transaction, the director directly owned 22,361 shares in the company, valued at approximately $5,410,467.56. The trade was a 15.53% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,709 shares of company stock worth $4,546,940. Insiders own 1.07% of the company’s stock.

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Articles

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.